📰 Patrick Wen News
Page 3 - Patrick Wen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Wen. Real-time updates on events, politics, business and more.
November 2, 2022
Milwaukee, WI (PRWEB) November 02, 2022 -- The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2022,
July 12, 2022
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has launched a new Scientific Advisory Board (SAB) consisting of four distinguished clinicians and scientists...
July 12, 2022
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its...
July 11, 2022
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has launched a new Scientific Advisory Board (SAB) consisting of four distinguished clinicians and scientists...
April 21, 2022
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has wrapped up its Phase 2 study of the glioblastoma treatment paxalisib. The company has received the final...
December 4, 2021
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce positive final data...
December 4, 2021
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce positive final data...
December 4, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
December 3, 2021
For personal use only ASX RELEASE 3 December 2021 KAZIA ANNOUNCES POSITIVE... | December 2, 2021
November 26, 2021
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.